Can an app supporting psoriasis patients improve adherence to topical treatment? A single-blind randomized controlled trial

BACKGROUND: Topical corticosteroid or corticosteroid/calcipotriol preparations are recommended first-line topical treatments of psoriasis, but a main cause for the lack of efficacy of topical treatments is considered low rates of adherence to topical drugs. Patient support by the use of applications...

Descripción completa

Detalles Bibliográficos
Autores principales: Svendsen, Mathias Tiedemann, Andersen, Flemming, Andersen, Kirsten Hammond, Andersen, Klaus Ejner
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804085/
https://www.ncbi.nlm.nih.gov/pubmed/29415699
http://dx.doi.org/10.1186/s12895-018-0071-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804085/
https://www.ncbi.nlm.nih.gov/pubmed/29415699
http://dx.doi.org/10.1186/s12895-018-0071-3

Ejemplares similares